Interleukin-1 in the pathogenesis and treatment of inflammatory diseases - Test2 - elhamkhani - TriplyDB

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

http://www.wikidata.org/entity/Q24606766

about

Activation of P2X(7) receptor by ATP plays an important role in regulating inflammatory responses during acute viral infection Heart failure with preserved ejection fraction: emerging drug strategies IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G Inflammatory Biomarkers Profile as Microenvironmental Expression in Keratoconus Signaling Interplay between Bone Marrow Adipose Tissue and Multiple Myeloma cells Is the risk of cardiovascular disease altered with anti-inflammatory therapies? Insights from rheumatoid arthritis Regulatory Role of IL-1R8 in Immunity and Disease The IL-1 cytokine family and its role in inflammation and fibrosis in the lung The Use of IL-1 Receptor Antagonist (Anakinra) in Idiopathic Recurrent Pericarditis: A Narrative Review From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection Macrophage Expression of Inflammatory Genes in Response to EMCV Infection Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory Drugs A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis Lighting the fires within: the cell biology of autoinflammatory diseases Addressing unmet medical needs in type 2 diabetes: a narrative review of drugs under development The Role of Damage-Associated Molecular Patterns in Human Diseases: Part I - Promoting inflammation and immunity Expanding the clinical indications for α(1)-antitrypsin therapy Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis?Subversion of cytokine networks by virally encoded decoy receptors A clear and present danger: inflammasomes DAMPing down disorders of pregnancy Targeting interleukin-1 in heart disease The TLR and IL-1 signalling network at a glance Embryo implantation: role of interleukin 1 family members GPER signalling in both cancer-associated fibroblasts and breast cancer cells mediates a feedforward IL1β/IL1R1 response.Anti-Interleukin-1 Agents in Adult Onset Still's Disease Crystal Structure of Mycobacterium tuberculosis Zinc-dependent Metalloprotease-1 (Zmp1), a Metalloprotease Involved in Pathogenicity Design of a superior cytokine antagonist for topical ophthalmic use IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections Interleukin-1 loop model for pathogenesis of Langerhans cell histiocytosis Dietary modulation of the microbiome affects autoinflammatory disease Efficient discovery of anti-inflammatory small-molecule combinations using evolutionary computing Interleukin-1β Processing Is Dependent on a Calcium-mediated Interaction with Calmodulin Central and haematopoietic interleukin-1 both contribute to ischaemic brain injury in mice The alarmin IL-1α is a master cytokine in acute lung inflammation induced by silica micro- and nanoparticles Silver nanoparticles induce degradation of the endoplasmic reticulum stress sensor activating transcription factor-6 leading to activation of the NLRP-3 inflammasome IL-1R signalling is critical for regulation of multi-walled carbon nanotubes-induced acute lung inflammation in C57Bl/6 mice The PYRIN Domain-only Protein POP1 Inhibits Inflammasome Assembly and Ameliorates Inflammatory Disease Aryl hydrocarbon receptor (AhR) regulates silica-induced inflammation but not fibrosis

P2860

Q21134608-6336361A-2E17-4C4B-A67C-B10599AEDF97 Q24595118-4F39D8E8-574D-4F1B-AF85-CA7E748C339E Q24633495-6073FD5F-61A3-442E-AA49-E4C7B8DA0B15 Q26738858-F8D32B2A-4BBA-4CF6-B931-2B867E351137 Q26744596-C1B177E5-41AD-4E08-8654-C3A2E366A6DC Q26746659-A7261194-658F-4EC5-89F3-A19BEFDAD148 Q26752524-5B0A395E-93D0-406C-A2B8-58964D740CAA Q26752849-0B1D3ACF-F3AB-4EFD-9CC6-581B0083F350 Q26768281-43588A6F-F2FE-43BA-927F-DCF763CE205E Q26770209-85C783DA-A23B-402C-9054-5EB681830D8C Q26795779-3AEDF6F1-B26B-4F0D-BDA2-D81F9800FE7F Q26799747-0F3B1EEE-E481-4302-86C3-E49F392AD481 Q26799767-2DF9EBEC-2058-46AB-85DE-7308737120CC Q26800158-E4B96D32-D6BA-4407-8319-C7234308F1B0 Q26823326-3980CF55-79C4-4CF1-B8F1-4879C2F444A3 Q26827163-3D6B36C8-E89E-4869-8807-074145C72641 Q26830274-3A5EEEE4-1961-4D7D-BB09-2B44D32FF39E Q26864215-80250D6A-6B68-4322-9623-CCFDB99584C3 Q27000764-971F0867-4FCE-4EDD-AEF0-B5D17A858AA5 Q27002805-34A03849-2621-4DCE-8DF4-10C0BD7924EB Q27005694-2061B624-AB08-47C4-9493-916FAD9638D0 Q27007734-8CFC11A1-3C86-44BA-94AC-FE0270BF69E5 Q27009347-8002397E-E7EB-4711-8AA2-011D2973EAF4 Q27013358-13867561-B91E-4DDA-BE2A-F968E78C7E34 Q27026276-748BED8D-562A-42AB-A976-AA440617CB6E Q27322202-C889491C-25AF-4358-AB6B-9D12AC951E2A Q27495968-DE5617D5-53F6-459A-BABD-70C78C949E4D Q27671497-E37EE96B-EBD3-4C7B-A02D-7BA15E483F03 Q27676526-87056D9C-F695-448A-BDB1-A983DE94E4BA Q28072571-8353D877-EC7B-4939-9E4B-2CCB3135C865 Q28083455-E8C9A113-B49E-41F7-BBCF-D50EEDFF40DD Q28249017-7AE30DFF-72BA-4019-AB8E-6DA7AB0D5EE2 Q28251171-74A25416-15E0-4FAB-A2CC-7BD78AC64BEB Q28269704-CB3023E2-6A8D-4877-A3D0-3E86CB55F928 Q28287669-467A6BE5-85FA-4C45-8822-FC1FEC0DF258 Q28385117-6D87672C-F8BA-4E31-821A-70480C3A575C Q28388753-B077DBDC-2DB0-4C43-A67F-B3A0D1615C1B Q28389369-ED59E0D2-B7FA-49C0-BB4F-9B115CC52DB0 Q28395210-C895D39C-EFA2-4C4C-81B4-9AB384DA1373 Q28397728-7E39A211-B626-4894-A192-D9B4B779B2D1

P2860

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

http://www.wikidata.org/entity/Q24606766

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

@ast

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

@en

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

@nl

type

label

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

@ast

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

@en

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

@nl

prefLabel

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

@ast

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

@en

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

@nl

P1433

Q24606766-AE64474F-933B-4B70-84CE-988BFDE878A9

P1476

Q24606766-3D04192A-E126-4A61-83D3-1B2A96047F0D

P2860

Q24606766-0354FE87-4EDA-46B0-8384-55938D037131

Q24606766-05E825AA-9A78-4AF3-BEF6-4F6A664CC324

Q24606766-0704B164-68BE-461F-9604-EA8F95FE0ADD

Q24606766-0E968A29-BCAE-483C-A282-2A2668C32820

Q24606766-121E06E8-C8C2-4632-8D35-43D7E33F9374

Q24606766-131019F4-B173-4D4E-82A0-9C8D5017A42C

Q24606766-167C24B8-ABBF-40CA-B142-CD914932EEF5

Q24606766-1754B148-50C5-42EC-B4FB-E4A1474D845C

Q24606766-19175ADD-684A-4CC4-9C42-0F5F4007BA86

Q24606766-1B0DBEEB-17C0-4491-9D3E-FCDF72F37D11

P304

Q24606766-6B455C4D-816E-4837-8A1E-825BB6B1C16F

P31

Q24606766-BFFEC17B-BE85-47BC-9764-4B40CC917BAB

P3181

Q24606766-FCDA0658-9578-4CFE-B3C4-9AAC8EEE10A6

P356

Q24606766-5C934F94-021A-4137-8070-24733E18AD8E

P407

Q24606766-83876AAE-6AC4-4B88-9EC2-C7A940B40CFD

P433

Q24606766-75B6EFCB-68ED-4227-B444-6D11D9985478

P478

Q24606766-96A352AA-0F08-472A-90EE-F819DF78CF2E

P50

Q24606766-BC08867C-B2BF-4EAE-AE3F-7DF2F6EC897F

P577

Q24606766-77CA079D-C62B-48F7-B1D8-2EAB00B9FBAD

P5875

Q24606766-744CCB5A-E317-40EE-B398-57156F05E332

P698

Q24606766-84CBD834-8CD5-455B-BED7-77DFC400D69E

P921

Q24606766-02E86F73-1763-488E-84CE-8E2B14D94722

Q24606766-26958A33-9675-4966-AEAD-9A8E1893B421

Q24606766-AD8A3E27-1BD0-4DAF-B3A7-1A8105942F73

Q24606766-a9df02f2-3fc2-416e-b105-95db8d75df90

P932

Q24606766-C5824B73-567A-40F6-95DD-EF966A954453

P3181

P356

BLOOD-2010-07-273417

P1433

P1476

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

@en

P2860

A pilot study of IL-1 inhibition by anakinra in acute gout

Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome

Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4

SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling

NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder

An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist

Reactive oxygen species-independent activation of the IL-1beta inflammasome in cells from patients with chronic granulomatous disease

Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)

Differential release of chromatin-bound IL-1alpha discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation

IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation

P304

3720-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

148960

http://www.w3.org/2001/XMLSchema#string

P356

10.1182/BLOOD-2010-07-273417

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P50

Charles A. Dinarello

P577

2011-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49820173

http://www.w3.org/2001/XMLSchema#string

P698

21304099

http://www.w3.org/2001/XMLSchema#string

P921

P932

3083294

http://www.w3.org/2001/XMLSchema#string